-
1Progress and prospective of plant sterol and plant stanol research: Report of the Maastricht meeting
المؤلفون: Mackay D., Clifton P.M., Jones P.J.H., Awad A., Chapman J., Baker P.C., Gylling H., Jones P., Lutjohann D., Marz W., Moreau B., Ostlund R., Plat J., Rideout T., Ros E., Schaefer E., Daniel T., Vartiainen E., Weingartner O., Zampelas A., Berger A., Wester I., Rosin S., Meijer G., Trautwein E., Ras R., Antoine J.-M., Jeansen S., Koutnikova H., Short C., Messinger H., Horlacher P., Ehrhardt C., Brañes C., Harting T., Thompson G., Tikkanen M., Shaghaghi M.A., Baer D., Ansorena D., Baumgartner S., Blanco-Vaca F., Ellegard L., Carles J., Laitinen K., Myrie S., Miettinen T., Mymin D., Robinson M., Rompelberg C., Sarkkinen E., Silbernagel G., de Smet E., Loman S.
المصدر: ATHEROSCLEROSIS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instnameمصطلحات موضوعية: phytosterol, food intake, nonhuman, concentration (parameters), consensus development, antineoplastic activity, stanozolol, low density lipoprotein cholesterol, unclassified drug, drug efficacy, drug formulation, priority journal, plant stanol, lipid metabolism, human, Alzheimer disease, atherosclerosis, antilipemic agent, antineoplastic agent, conference paper, Netherlands